Caribou Biosciences, Inc.CRBUNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank83
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-1.00
↑ 87% vs avg
Percentile
P83
Within normal range
Streak
1 yr
Consecutive declineElevated
Average
-7.99
Historical baseline
PeriodValueYoY Change
2025-1.00-4.1%
2024-0.96+76.8%
2023-4.14-7.9%
2022-3.84+71.7%
2021-13.59-3.3%
2020-13.16+31.7%
2019-19.26-